Interim Results from Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma

News   Dec 10, 2013

 
Interim Results from Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
 
 
 
FURTHER INFORMATION
 

This content appears on:

Cell Science

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT